The following is a summary of “Incidence and reasons for discontinuation of anti-VEGF treatment in neovascular age-related macular degeneration,” published in the March 2025 issue of British Journal ...

Anti-VEGF therapy improves outcomes in retinal diseases by targeting neovascularization and macular edema, crucial in conditions like AMD and diabetic retinopathy. Optical coherence tomography is ...

could be considered the “previous generation” of anti-VEGF drugs. Currently, the next step for KOD is its topline data readout for DR in 1Q 2026 and for wet AMD in 2Q 2026. Also, both trials ...

The Eylea franchise was in need of a win after an appellate court last week denied the pharma’s bid to block Amgen’s ...

How is AMD diagnosed? Since macular degeneration ... These classes of drugs are called Anti VEGF (vascular endothelial growth factor) which are delivered in the form of injections in the eye.

“Given the high treatment burden of current anti-VEGF therapies for wet AMD, there remains a need for more sustainable and less frequent treatment while maintaining visual acuity alongside the ...

For wet AMD, you can slow or stop symptoms and possibly reverse vision changes with anti-VEGF injections. Find out how wet AMD can affect vision loss and your eye health. AMD is a common age ...

1 Cho H, Shah CP, Weber M, Heier JS. Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab. Br J Ophthalmol 2013;97(8):1032–5. 2 Bakall B, Folk JC, Boldt HC ...

Clearside Biomedical (CLSD) announced that presentations on the Company’s lead clinical program, CLS-AX in neovascular age-related macular ...

Macular degeneration, particularly age-related macular degeneration (AMD), is a leading cause of vision loss worldwide. This ...